AlzeCure Publishes the Positive Clinical Results from the Phase I Trial of NeuroRestore ACD856 Against Alzheimer’s

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / August 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

Phonak Expands Lumity Portfolio, Empowering Kids and Adults With Various Types of Hearing Loss To Enjoy Conversations

2 years ago

New Sky, Naída and CROS address the unique needs of kids, teens, and adults. Lumity is now suitable for a…

Science & Humans (S&H) Welcomes Esteemed Canadian Endocrinologist & Geneticist Dr. Fady Hannah-Shmouni to Medical Advisory Board

2 years ago

MISSISSAUGA, ON / ACCESSWIRE / August 8, 2023 / Science & Humans (S&H), a health and wellness company focused on…

Model N Announces Third Quarter Fiscal Year 2023 Financial Results

2 years ago

Total Revenue Grew 13% Year-over-Year SaaS ARR Grew 28% Year-over-YearSAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in…

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

2 years ago

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the…

Establishment Labs Reports Record Second Quarter 2023 Financial Results

2 years ago

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

NHI Announces Second Quarter 2023 Results

2 years ago

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the…

NHI Announces Third Quarter 2023 Dividend

2 years ago

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay…

NHI Issues Investor Update

2 years ago

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update…

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

2 years ago

Reports Net Revenues of $145.7 Million for the Three Months Ended June 30, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / August…